Drug intelligence / Profile preview

(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide

Development stage
Preclinical
Modality
Small Molecules
01

Overview

(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide is a synthetic small molecule belonging to the benzenesulfonamide class. It was designed as a potent and selective inhibitor of human carbonic anhydrase II (CA II), an enzyme involved in the reversible hydration of carbon dioxide. The compound exhibits picomolar affinity for CA II, with the R-enantiomer showing higher potency than its S-enantiomer. Its mechanism involves binding to and inhibiting the catalytic activity of CA II, which plays roles in pH regulation and CO₂ transport. This compound has been studied primarily as a chemical probe or lead structure for drug discovery rather than as a marketed pharmaceutical agent[1][6][7].

Other names
N-[(2R)-3-(1H-indol-1-yl)-2-methylpropyl]-4-sulfamoylbenzamideBenzamide, 4-(aminosulfonyl)-N-[(2R)-3-(1H-indol-1-yl)-2-methylpropyl]-
02

Targets

CA2 (Carbonic Anhydrase 2)

Beyond the preview

Go deeper on (R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call